Quantcast

Latest surgical site infections Stories

2009-12-16 11:39:12

Post-surgical infections significantly increase the chance of hospital readmission and death and cost as much as $60,000 per patient, according to Duke University Medical Center researchers who conducted the largest study of its kind to date. "We conducted a multi-center study of multiple surgical procedure types among 659 patients to determine clinical and financial outcomes of surgical site infections that are directly attributable to MRSA (methicillin-resistant Stapylococcus aureus)," said...

2009-10-05 14:36:31

UVA study published in leading infection control journal 3M Health Care today announced the publication of a new independent study "Effects of Preoperative Skin Preparation on Postoperative Wound Infection Rates: A Prospective Study of 3 Skin Preparation Protocols," that compared the effects of three different skin preparation solutions on surgical-site infections. The study found that Iodophor-based skin preparation solutions, such as 3Mâ“ž¢...

2009-08-25 11:00:00

SAN DIEGO, Aug. 25 /PRNewswire-FirstCall/ -- Data published in The Journal of Bone and Joint Surgery demonstrates that use of the preoperative skin preparation ChloraPrep((R) )from CareFusion is significantly more effective than both DuraPrep and povidone-iodine at eliminating overall bacteria from the shoulder region. After antisepsis with ChloraPrep (2 percent chlorhexidine gluconate and 70 percent isopropyl alcohol), only seven percent of skin cultures tested positive for bacteria...

2009-03-19 06:00:00

ASHBURN, Va., March 19 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the second of two ongoing U.S. phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections. The trial is being conducted at approximately 45 hospital sites across the U.S. and has enrolled 600 patients undergoing...

2009-03-16 06:00:00

ASHBURN, Va., March 16 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the first of two ongoing U.S. phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections. The trial is being conducted at approximately 50 hospital sites across the U.S. and has enrolled 1,500 diabetic and/or...

2009-01-26 07:00:00

CleanFUZE(TM) antimicrobial device to significantly reduce surgical site infections (SSIs) and potentially save the healthcare system $150 million dollars annually AUSTIN, Texas, Jan. 26 /PRNewswire/ -- DiFUSION Technologies, Inc., a medical device company targeting the orthopaedic market, has successfully completed a series of laboratory tests of its silver ion-based antimicrobial technology designed to mitigate Surgical Site Infections (SSIs) in spinal surgery. The technology will be...

2009-01-06 07:00:00

AUSTIN, Texas, Jan. 6 /PRNewswire/ -- DiFUSION Technologies, Inc., a medical device company targeting the orthopaedic market, today announced its corporate launch. The company will focus on reducing the rising incidence of Surgical Site Infections (SSIs) in spinal surgeries. "In large studies, five out of 100 spine cases result in SSIs often leading to second surgeries that are extremely costly and difficult for the patient," said Dr. Matthew Geck, founder and board member of...

2008-09-26 06:00:31

TyRx, Inc., a leader in the development and commercialization of convergent drug-device medical products, announced today the launch of AIGISRX(TM) ICD, an anti-bacterial envelope developed to help stabilize the implanted device and which also contains anti-microbial agents that help provide protection against surgical site infections (SSI) associated with implantable cardioverter defibrillators (ICDs). The launch of AIGISRX ICD extends TyRx's AIGISRX CRMD (cardiac rhythm management device)...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related